Use of Methohexital and Dexmedetomidine for Maintenance of Anesthesia in a Patient With Mitochondrial Myopathy: A Case Report.
Provision of anesthesia for patients with mitochondrial disorders is associated with a unique set of challenges. These disorders are rare, which complicates efforts to develop high quality, evidence-based guidelines to inform the perioperative management of those who suffer from them. Accordingly, case reports remain an important source of information regarding their care. Here we present the case of a 27-year-old female patient with mitochondrial myopathy and a history suggestive of malignant hyperthermia susceptibility who received general anesthesia for 2 consecutive surgeries. The induction agents included fentanyl, ketamine, and methohexital. The maintenance agents were methohexital, sufentanil, and dexmedetomidine.
From the *Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Boston, Massachusetts; and †Harvard Medical School, Boston, Massachusetts.
Elliott L
EL
Woodward
Zhiling
Z
Xiong
D000328:Adult; D000768:Anesthesia, General / Q000379:methods*; D020927:Dexmedetomidine / Q000008:administration & dosage*; D005260:Female; D005283:Fentanyl / Q000008:administration & dosage; D006801:Humans; D007649:Ketamine / Q000008:administration & dosage; D008305:Malignant Hyperthermia / Q000517:prevention & control*; D008723:Methohexital / Q000008:administration & dosage*; D017240:Mitochondrial Myopathies / Q000601:surgery*; D017409:Sufentanil / Q000008:administration & dosage; D016896:Treatment Outcome
D020927:Dexmedetomidine; D007649:Ketamine; D017409:Sufentanil; D008723:Methohexital; D005283:Fentanyl